Literature DB >> 8910836

Compliance with supportive periodontal therapy and its relation to the bleeding index.

A B Novaes1, F R de Lima, A B Novaes1.   

Abstract

This is a retrospective study of 418 patients who received active periodontal treatment between the years of 1984 and 1990. The patients were instructed to return for supportive periodontal treatment (SPT) at 3 to 6-month intervals. The objective of this study was to evaluate patient compliance with periodic recall visits, and to study the relationship of bleeding upon probing in those who returned regularly. The patients were divided into 3 groups: patients who returned periodically for supportive treatment, patients who interrupted the proposed maintenance treatment, and patients who never returned after active periodontal treatment. Analysis was made for each group to correlate the degree of compliance with gender, disease classification, and type of treatment received. To analyze bleeding upon probing, 2 groups of patients were selected: a test group with 39 patients who had attended at least 10 recall visits and participated in the study for more than 40 months, and a control group of 21 patients who interrupted the SPT for at least 12 months. The results showed that 26% of the treated patients returned for SPT and, of those, 40% returned irregularly. There was a statistical significant difference in compliance in relation to disease classification and the type of treatment received, but no correlation was found between compliance and gender. There was a statistically significant difference in compliance between the test group and the control group in relation to the variation of the bleeding index.

Entities:  

Mesh:

Year:  1996        PMID: 8910836     DOI: 10.1902/jop.1996.67.10.976

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  8 in total

1.  What factors influence patient compliance with supportive periodontal therapy in a general practice setting?

Authors:  C Perrell-Jones; R S Ireland
Journal:  Br Dent J       Date:  2016-12-09       Impact factor: 1.626

Review 2.  Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.

Authors:  W J Loesche; N S Grossman
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Influence of Anti-Infective Periodontal Therapy on Subgingival Microbiota Evaluated by Chair-Side Test Compared to qPCR-A Clinical Follow-Up Study.

Authors:  Oliver Laugisch; Thorsten M Auschill; Anne Tumbrink; Anton Sculean; Nicole B Arweiler
Journal:  Antibiotics (Basel)       Date:  2022-04-26

4.  A 5-year prospective study on regenerative periodontal therapy of infrabony defects using minimally invasive surgery and a collagen-enriched bovine-derived xenograft.

Authors:  Thomas De Bruyckere; Aryan Eghbali; Faris Younes; Roberto Cleymaet; Wolfgang Jacquet; Hugo De Bruyn; Jan Cosyn
Journal:  Clin Oral Investig       Date:  2017-09-30       Impact factor: 3.573

5.  Compliance to recall visits by patients with periodontitis - Is the practitioner responsible?

Authors:  Angel Fenol; Simi Mathew
Journal:  J Indian Soc Periodontol       Date:  2010-04

6.  Compliance improvement in periodontal maintenance.

Authors:  Verônica Franco de Carvalho; Osmar Shizuo Okuda; Carlos Cheque Bernardo; Cláudio Mendes Pannuti; Marco Antonio Paupério Georgetti; Giorgio De Micheli; Francisco Emílio Pustiglioni
Journal:  J Appl Oral Sci       Date:  2010 May-Jun       Impact factor: 2.698

7.  Evaluation of prognosis related to compliance with supportive periodontal treatment in patients with chronic periodontitis: a clinical retrospective study.

Authors:  Jong-Bin Lee; Hye-Jung Shin; Dae-Yeob Kim; Eun-Kyoung Pang
Journal:  J Periodontal Implant Sci       Date:  2019-04-17       Impact factor: 2.614

8.  A comprehensive periodontal treatment project: The periodontal status, compliance rates, and risk factors.

Authors:  Kuo-Ching Huang; Chao-Han Lai; Chiung-Fang Huang; Hsein-Kun Lu
Journal:  J Dent Sci       Date:  2015-11-19       Impact factor: 2.080

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.